Your browser doesn't support javascript.
loading
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease.
Jiang, Yuanbing; Zhou, Xiaopu; Wong, Hiu Yi; Ouyang, Li; Ip, Fanny C F; Chau, Vicky M N; Lau, Shun-Fat; Wu, Wei; Wong, Daniel Y K; Seo, Heukjin; Fu, Wing-Yu; Lai, Nicole C H; Chen, Yuewen; Chen, Yu; Tong, Estella P S; Mok, Vincent C T; Kwok, Timothy C Y; Mok, Kin Y; Shoai, Maryam; Lehallier, Benoit; Losada, Patricia Morán; O'Brien, Eleanor; Porter, Tenielle; Laws, Simon M; Hardy, John; Wyss-Coray, Tony; Masters, Colin L; Fu, Amy K Y; Ip, Nancy Y.
Afiliação
  • Jiang Y; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Zhou X; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Wong HY; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Ouyang L; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Ip FCF; Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development; Shenzhen-Hong Kong Institute of Brain Science, HKUST Shenzhen Research Institute, Shenzhen, China.
  • Chau VMN; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Lau SF; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Wu W; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Wong DYK; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Seo H; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Fu WY; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Lai NCH; Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development; Shenzhen-Hong Kong Institute of Brain Science, HKUST Shenzhen Research Institute, Shenzhen, China.
  • Chen Y; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Chen Y; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Tong EPS; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Mok VCT; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Kwok TCY; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Mok KY; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Shoai M; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Lehallier B; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Losada PM; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • O'Brien E; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Porter T; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Laws SM; Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.
  • Hardy J; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Wyss-Coray T; Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development; Shenzhen-Hong Kong Institute of Brain Science, HKUST Shenzhen Research Institute, Shenzhen, China.
  • Masters CL; The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences; Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen, China.
  • Fu AKY; Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
  • Ip NY; Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development; Shenzhen-Hong Kong Institute of Brain Science, HKUST Shenzhen Research Institute, Shenzhen, China.
Nat Aging ; 2(7): 616-634, 2022 07.
Article em En | MEDLINE | ID: mdl-37117777
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article